Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS …
L Assoumou, R Baldé, C Katlama… - Journal for …, 2024 - pmc.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) have been a major advance in cancer
management. However, we still lack prospective real-world data regarding their usage in …
management. However, we still lack prospective real-world data regarding their usage in …
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials
NJ Shah, A Della Pia, T Wu, A Williams, M Weber… - Cancers, 2024 - mdpi.com
Simple Summary Immune checkpoint inhibitors (ICIs) are a type of immunotherapy used to
treat a variety of cancers by helping a patient's own immune system to kill cancer cells. ICIs …
treat a variety of cancers by helping a patient's own immune system to kill cancer cells. ICIs …